This is one I have held for a number of years. Buying in at these levels and averaging out from 1.20. The yield has been reasonable but debt is always the issue because of the capital intensity of the business. The DDH1 acquisition share overhang may be an issue. The acquisitions have not always been the best in past. Lets see what happens?
- Forums
- ASX - By Stock
- PRN
- Good Value and Momentum
PRN
perenti limited
Add to My Watchlist
0.63%
!
$1.59

Good Value and Momentum, page-100
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$1.59 |
Change
-0.010(0.63%) |
Mkt cap ! $1.471B |
Open | High | Low | Value | Volume |
$1.60 | $1.62 | $1.57 | $2.768M | 1.742M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 8677 | $1.58 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.60 | 8677 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 41000 | 1.560 |
1 | 12862 | 1.555 |
1 | 645 | 1.550 |
1 | 1294 | 1.545 |
2 | 3880 | 1.540 |
Price($) | Vol. | No. |
---|---|---|
1.600 | 2500 | 1 |
1.605 | 8502 | 1 |
1.610 | 10000 | 1 |
1.620 | 87221 | 5 |
1.625 | 6370 | 1 |
Last trade - 16.10pm 27/06/2025 (20 minute delay) ? |
Featured News
PRN (ASX) Chart |
The Watchlist
PAR
PARADIGM BIOPHARMACEUTICALS LIMITED..
Paul Rennie, MD & Founder
Paul Rennie
MD & Founder
SPONSORED BY The Market Online